INTRODUCTION
Influenza virus infection causes an acute respiratory tract disease with a global annual mortality of 250 000-500 000. 1, 2 In addition to seasonal strains, humans face the persistent threat of novel strains that can emerge and spread quickly in a naive population, potentially resulting in a pandemic. 3, 4 Seasonal influenza often affects individuals with weakened immune systems including very old, very young and immunocompromised populations. [5] [6] [7] Conversely, certain highly pathogenic influenza viruses such as the 1918 H1N1 strain confer greater mortality in otherwise healthy individuals through a combination of enhanced inflammation leading to excessive tissue damage and secondary bacterial infection. 8, 9 To develop effective management strategies to combat both seasonal and pandemic influenza infection, a detailed understanding of the cellular and molecular mechanisms that regulate the quality and magnitude of the host immune response is essential.
Following influenza infection, a rapid yet nonspecific innate immune response is activated in an attempt to control initial viral replication and is followed by the mobilization of professional antigen-presenting cells including dendritic cells (DCs) and macrophages. Activated antigen-presenting cells express class I or class II major histocompatibility complex (MHC) molecules as well as co-stimulatory markers such as the cluster of differentiation (CD) molecules CD40, CD80 and CD86. 10 Expression of these markers, particularly by DCs, is required for the priming and activation of naive T and B cells in the lung-associated lymph nodes (LALNs), leading to the formation of an adaptive immune response. [11] [12] [13] [14] [15] Activated T and B cells are recruited to the site of primary infection to mediate antigen-specific immunity through cell-mediated control of viral replication and the production of specific antibodies that provide lasting protection against the infecting strain, respectively. 10 Initial recognition of the influenza virus and subsequent activation of innate immunity occurs through host pattern recognition receptors. Two of the best-studied pattern recognition receptors for influenza recognition are the endosomal Toll-like receptors (TLR)3 and TLR7. [16] [17] [18] [19] [20] To initiate downstream signaling, TLR3 and TLR7 must be trafficked from the endoplasmic reticulum to the endosome by UNC93B1, an endoplasmic reticulum-resident transmembrane chaperone protein that also transports TLR9 following activation. [21] [22] [23] At the endosome, TLR7 recognizes viral single-stranded RNA and recruits the myeloid differentiation primary response 88 (MyD88) adaptor protein, 16, 20 while TLR3 recognizes double-stranded RNA and recruits the Toll interleukin-1 receptor-domain-containing adapter inducing interferon-b (TRIF) adaptor protein. 24 One group has shown that MyD88-deficient mice are susceptible to influenza infection and have diminished recruitment of CD11b þ neutrophils and monocytes as well as reduced expression of the proinflammatory mediators interleukin-6 (IL-6), tumor necrosis factor-a and interferon (IFN)-g in the airways. 25 A role for MyD88 in B-cell activation and subsequent production of virus-specific IgG2a/c antibodies has also been demonstrated. 18, 26 Conversely, several other investigations have demonstrated that signaling via MyD88 is not essential for survival following influenza challenge.
Despite conflicting reports as to whether a true doublestranded RNA replication intermediate forms during influenza virus replication, TLR3 expression is upregulated in human alveolar and bronchial epithelial cells as well as mouse lungs following influenza infection, suggesting that it contributes to the host immune response. 17, 19, 28, 29 TLR3 has been specifically linked to the early production of proinflammatory mediators such as IL-6, IL-8 and CCL5 in human bronchial cells during influenza infection. 17, 19 Compared with wild-type mice, TLR3-deficient mice have diminished production of IL-6 and IL-12 p40/p70, elevated expression of IL-9, IL-10 and IFN-g, and fewer macrophages and CD8 þ T cells in the airways. 28 Somewhat unexpectedly, these mice had an improved rate of survival despite a higher lung viral load, suggesting that the TLR3-mediated host response during influenza infection is deleterious. 28 On the other hand, subsequent studies of TRIF-deficient mice that also lack TLR3 signaling did not reveal a significant role for this adaptor molecule following influenza infection. 25, 26 Finally, analysis of a single patient with influenza-associated encephalopathy revealed a loss-of-function missense mutation in TLR3, suggesting that this pattern recognition receptor may have a crucial role in protection rather than disease pathogenesis. 30 Although the discordant experimental findings on the role of these TLRs and adaptor molecules in influenza infection may be attributable to differences in the strain, dose and volume of virus administered to mice with distinct genetic backgrounds, complementary human studies have also failed to clearly identify the genes that are required for protection of the host. 31 Thus, on the basis of current knowledge, it is not possible to draw firm conclusions about the contributions of the TLR7-MyD88 and TLR3-TRIF signaling pathways to innate immunity against influenza infection.
Studies of inbred mouse strains as well as gene-deficient mice have been essential for elucidating key features of the host response to viral infection that are relevant to human immunity. 32, 33 Owing to the limited number of available inbred and knockout strains, alternative approaches, such as the creation of random heritable mutations using the chemical N-ethyl-Nnitrosourea (ENU), have evolved in recent years. 32 Rather than abrogating gene expression, ENU mutagenesis can create unique point mutations that alter protein function. 34 Such mutations more closely mirror human genetic variation and can reveal specific roles for individual protein domains. 34 This forward genetic approach has been successfully used to study molecules and pathways that are crucial to host defense against various pathogens. 35 Here we report the creation of an ENU-induced point mutation in the mouse Unc93b1 gene that results in the complete deletion of exon 4, which encodes the third and fourth transmembrane domains of the full-length protein. We have named this mutation Letr for 'loss of endosomal TLR response' as it confers a lack of responsiveness to stimulation with nucleic acid structures that represent pathogen-associated molecular patterns (PAMPs) known to activate the TLR3, TLR7 and TLR9 signaling pathways.
Based on the previously demonstrated function of UNC93B1 as a chaperone for endosomal TLRs [21] [22] [23] as well as its contribution to the immune response against various parasites (Toxoplasma gondii, Trypanosoma cruzi and Leishmania major), [36] [37] [38] [39] [40] DNA viruses (mouse cytomegalovirus (MCMV) and Herpes simplex virus-1) [41] [42] [43] and neuroadapted Sindbis virus (a positive-sense single-stranded RNA virus), 44 we hypothesized that defective UNC93B1 function would impair the innate immune response to influenza A/PR/8/34 (H1N1), a negative-sense single-stranded RNA virus that targets the respiratory mucosa. Using our ENU-induced mutant mice that lack endosomal TLR signaling, we found that Unc93b1 contributes to the expression of type I IFN (IFN-a/b) and type II IFN (IFN-g), recruitment of activated exudate macrophages (ExMs), and activation of T cells in the lung during the early phase of influenza infection. Importantly, despite a significant delay in viral clearance that coincided with increased tissue inflammation and epithelial reaction, the failure of Unc93b1-mediated innate immune activation did not significantly alter mortality, suggesting that alternative pathways can compensate for the lack of endosomal TLR function in this model. Collectively, these results establish a distinct role for Unc93b1 in the early activation of the innate immune response to influenza and demonstrate the importance of redundant mechanisms that protect the host against lethal infection.
RESULTS
ENU mutagenesis induced a mutation that confers defective in vitro and in vivo responses to TLR3, TLR7 and TLR9 ligands To identify novel genes or novel roles for known genes in TLRspecific immune signaling pathways, we injected male 129S1 G0 mice with ENU and screened cells from G3 mutagenized mice for defective responses to polyinosinic:polycytidylic acid (polyI:C), lipopolysaccharide (LPS), imiquimod and unmethylated CpG dinucleotides (CpG DNA). These structures were chosen as they are known to activate TLR3, TLR4, TLR7 and TLR9 signaling pathways, respectively. [45] [46] [47] [48] The cytokines, cell types and time points selected for analysis following in vitro and in vivo PAMP stimulation were based on data from the initial publications that identified these TLR ligands. [45] [46] [47] [48] Mutagenized G0 mice were bred to C57BL/6 female mice and the G1 progeny from independent G0 crosses were intercrossed to increase the number of recessive mutations available for screening at the G3 generation ( Figure 1a ). Thioglycollate-elicited peritoneal macrophages or splenocytes from G3 progeny of G2 brother-sister matings were tested for in vitro expression of IL-6 in response to PAMP stimulation. One pedigree (B28W6) showed a deviant phenotype in response to stimulation with polyI:C, imiquimod and CpG DNA but had normal expression following LPS stimulation (Figure 1b) . Heterozygous G2 fathers from this pedigree were outcrossed to C57BL/6 female mice and the resulting F1 female progeny were backcrossed to create N2 progeny (Figure 1a ). N2 mice were intercrossed and deviant lines carrying a homozygous mutation were identified by survival splenectomy and repeat in vitro phenotyping. Cells from heterozygous mice responded normally to CpG stimulation, confirming that the mutation has a recessive mode of inheritance ( Figure 1b) . To analyze the phenotype in vivo, progeny of deviant and normal N2 mice were injected intraperitoneally with LPS, polyI:C, imiquimod or CpG DNA and serum was collected 3 h after injection. Compared with the progeny of normal N2 mice, those from deviant N2 mice had significantly decreased expression of serum IL-12/IL-23 p40 in response to stimulation with polyI:C, imiquimod or CpG DNA but retained similar responses to LPS (Figure 1c ).
An ENU-induced single-nucleotide transversion in Unc93b1 results in the loss of exon 4 due to alternative splicing To map the gene responsible for the Letr phenotype, we performed a low-density genome scan using 375 single-nucleotide polymorphisms among 54 mice derived from a (Letr/Letr Â C3H/HeN) F1 Â Letr/Letr backcross. The Letr mutation was localized to a 5.4 Mb region on chromosome 19 between markers rs31277487 and rs30935927. To test the heritability of the Letr mutation, an additional 281 mice from the same backcross were screened for IL-6 expression following in vitro stimulation of splenocytes with CpG DNA. Of these mice, 139 (49.5%) showed a normal IL-6 response, while the other 142 (50.5%) mice lacked IL-6 expression with perfect concordance between the mutant phenotype and genotype for a recessive mutation.
Based on a previous ENU mutagenesis study that created a mouse, termed 3d, with a similar hyporesponsive phenotype caused by a point mutation in Unc93b1 on chromosome 19, 23 Unc93b1 mutation impairs influenza innate immunity EI Lafferty et al we took a targeted approach to identify the Letr mutation. Nucleotide sequencing of Unc93b1 genomic DNA from normal and deviant (Letr) mice identified a single T to A transversion at the 5 0 splice donor site in the intron between exons 4 and 5 of Unc93b1 that rendered the site ineffective (Figure 2a , non-coding strand shown). Sequencing of complementary DNA (cDNA) from both Unc93b1 þ / þ and Unc93b1 Letr/Letr mice determined that the mutation resulted in the loss of exon 4 in the 11-exon mRNA transcript (Figure 2c ).
To confirm that the ENU-induced Letr mutation caused alternative splicing, spleen RNA from Unc93b1
Letr/Letr and Unc93b1 þ /Letr mice as well as C57BL/6, C3H/HeN and 129S1 inbred strains was reverse transcribed and a 918-base pair (bp) region of Unc93b1 cDNA that included exon 4 was amplified and visualized by gel electrophoresis. All three inbred strains presented a single band at the predicted size, while Unc93b1
Letr/Letr cDNA presented a smaller band that is compatible with the 162-bp deletion of exon 4 ( Figure 2b ). Analysis of heterozygous Unc93b1 þ /Letr cDNA showed both wild-type and mutant Unc93b1 transcripts.
To evaluate the relative importance of exon 4 to the integrity of the UNC93B1 protein, the degree of amino-acid sequence conservation was compared among diverse species. Alignment of UNC93B1 amino-acid sequences encompassing exon 4 demonstrated a 54-amino-acid deletion in Unc93b1
Letr/Letr mice ( Figure 2d ). These missing amino acids were identical among all species examined, with the exception of Xenopus tropicalis that was distinguished by the substitution of nine amino-acid residues. Protein modeling software was used to confirm that the wild-type UNC93B1 amino-acid sequence forms a 12-helix transport protein (Figure 2e) . 23, 49 By mapping the amino acids encoded by exon 4 to the wild-type model, the splicing defect caused by the Letr mutation is predicted to eliminate the third and fourth transmembrane domains of the functional UNC93B1 protein and is distinct from the 3d mutation, which causes a single-amino-acid missense mutation (H412R) in the ninth transmembrane domain (Figure 2e ). mice. If the Letr mutation were elsewhere in the genome, the lack of response to PAMP stimulation would be rescued in the compound heterozygotes. All genotypes were tested for IL-6 expression following in vitro stimulation with PAMPs, as done during the initial screen. Both thioglycollate-elicited peritoneal macrophages and splenocytes stimulated with media alone produced undetectable levels of IL-6 (data not shown). Thioglycollate-elicited peritoneal macrophages from Unc93b1 Letr/Letr , Unc93b1 3d/3d and Unc93b1 Letr/3d strains had a comparable IL-6 response to Unc93b1 þ / þ mice following LPS stimulation ( Figure 3a) . Conversely, the Unc93b1 Letr/Letr , Unc93b1 3d/3d and Unc93b1 Letr/3d strains had significantly decreased or undetectable IL-6 expression compared with Unc93b1 þ / þ mice following stimulation with polyI:C, imiquimod or CpG DNA (Figures 3b-d ).
Unc93b1
Letr/Letr mice have fewer activated ExMs in the lungs following influenza infection UNC93B1 functions as a chaperone for TLR3, TLR7 and TLR9 and has a role in host defense against various pathogens including the DNA viruses MCMV and Herpes simplex virus-1 and the RNA virus neuroadapted Sindbis virus. [21] [22] [23] [41] [42] [43] [44] To determine if Unc93b1 also mediates innate immunity against RNA viral infection of the respiratory mucosa, we characterized the response of Unc93b1
Letr/Letr mice to experimental challenge with influenza A/ PR/8/34 (H1N1). TLR3, TLR7 and the MyD88 adaptor protein have been implicated in the immune response to influenza infection, albeit with variable outcomes. [16] [17] [18] 20, 25, 26, 28 Unc93b1 Letr/Letr mice provide a unique opportunity to determine the combined consequence of defective endosomal TLR3 and TLR7 activation in the presence of a functional MyD88 molecule that also participates in IL-1R-and IL-18R-mediated signaling. 50 As a role for Unc93b1 has been linked to antigen presentation during T. gondii infection, 38 we sought to determine whether the loss of Unc93b1 function would affect the activation of lung macrophages and DCs during influenza infection. 51 Based on the literature, day 3 was selected as a representative time point for characterization of early immune differences following experimental influenza challenge. 27, 28, 52 Initially, CD11c and MHCII were used to distinguish macrophages (CD11c þ MHCII int ) from DCs (CD11c þ MHCII hi ) and CD11b expression was then used to separate the former population into resident alveolar macrophages (AMs) (CD11b À ) and monocyte-derived ExMs Letr/Letr mice. (e) Predicted three-dimensional structure of wild-type UNC93B1 with the 3d (red) and Letr (yellow) mutations mapped to their respective protein domains. The amino-and carboxy-termini are indicated as N and C, respectively.
þ / þ mice at this time point (Figure 4c ). Simultaneous analysis of the LALNs showed that there was no significant difference in the number of CD80
þ DCs, while the number of CD80 þ ExMs was too low for reliable detection (Supplementary Figure 1D) , suggesting that the differential activation seen in the Unc93b1
Letr/Letr mice was restricted to the site of infection.
Loss of Unc93b1 function reduces CD4 þ and CD8 þ T-cell activation in the lungs following influenza infection As Unc93b1 also has a role in the activation of CD4 þ and CD8 þ T cells during T. gondii infection, 38 we analyzed the number and activation status of these lymphoid cell subsets in our model. Activated CD4 þ and CD8 þ T cells produce an antigen-specific response that contributes to control of lung viral load. Specifically, CD8 þ T cells function primarily through direct lysis of virally infected cells, while CD4 þ T cells are classically known as helper cells that enhance CD8
þ T-cell and B-cell activation and, more recently, have been shown to have a direct cytolytic function as well. [53] [54] [55] Flow cytometry analysis at days 0, 3 and 7 post infection did not reveal a difference in the total number of CD4 þ or CD8 þ T cells observed in the LALNs or lungs between Unc93b1 þ / þ and Unc93b1
Letr/Letr mice (Figures 5a and b and Supplementary Figure 2G ). To determine whether the loss of Unc93b1 altered T-cell activation during influenza infection, the surface expression of an early activation marker (CD69) as well as markers of a naive (CD62L) and effector (CD44) T-cell phenotype were evaluated at days 3 and 7 post infection. Representative expression plots for T-cell activation markers are displayed as histograms (Figures 5c-e Figures 2D-F) .
Letr/Letr mice have a selective decrease in type I/II IFN and CXCL10 expression during influenza infection Following influenza infection, the lungs produce a variety of soluble mediators that are involved in the recruitment and activation of innate and adaptive immune cells as well as the destruction of virally infected host cells. 10 To determine whether the diminished cellular activation in Unc93b1
Letr/Letr mice was associated with an altered pattern of inflammatory mediator secretion in the airway or lungs, the expression of representative cytokines and chemokines that have been implicated in the host response to influenza was determined at serial time points. At day 3 post infection, the expression of type I IFN was significantly lower in the airways of Unc93b1
Letr/Letr mice compared with the Unc93b1 þ / þ strain; however, at day 7 post infection a comparable increase was observed in both strains (Figure 6a ). Significantly lower expression of CXCL10 (Figure 6b ) and IFN-g (Figure 6c ) was also observed at day 3 post infection in the airway and lungs of Unc93b1
Letr/Letr mutants compared with the Unc93b1 þ / þ strain. The expression of other proinflammatory mediators in the airway, including the cytokines IL-6 and tumor necrosis factor-a, and the chemokines CCL2, CCL3, CXCL1 and CXCL2 was not significantly different at days 3 or 7 post infection (Supplementary Figure 3) . These findings demonstrate that soluble inflammatory mediator production at the site of infection was selectively altered by the loss of Unc93b1 function.
Letr/Letr mice have delayed viral clearance and increased tissue inflammation following influenza infection To determine if the significant differences in immune cell activation and inflammatory mediator expression caused by the loss of Unc93b1 function had an impact on host outcome following influenza infection, a comparative analysis of lung viral load, inflammation and mortality was conducted between Unc93b1 þ / þ and Unc93b1 Letr/Letr strains after intranasal challenge with 400 p.f.u. of the virulent influenza A/PR/8/34 (H1N1) strain. In both genotypes, the peak lung viral load was observed at day 3 post infection and decreased thereafter (Figure 7a) . 28, 56 Notably, at Unc93b1 mutation impairs influenza innate immunity EI Lafferty et al day 7 post infection, the lung viral load in Unc93b1 Letr/Letr mice was significantly higher compared with Unc93b1 þ / þ mice (Figure 7a ). In response to influenza challenge, both mouse strains showed a similar pattern of weight loss with a nadir at day 9 followed by recovery of initial weight in surviving animals by day 21 post infection ( Figure 7c) . 52 Under these experimental conditions, Unc93b1 þ / þ mice had a median survival time of 14 days and an overall mortality of 60%, while Unc93b1
Letr/Letr mice had a median survival time of 11.5 days and an overall mortality of 70% (Figure 7b ). These data suggest that the loss of Unc93b1 may be associated with an earlier onset of death but does not significantly affect the overall survival rate following severe influenza infection. Finally, analysis of lung tissue sections stained with hematoxylin and eosin at day 7 post infection demonstrated that Unc93b1
Letr/Letr mice had increased inflammation and signs of epithelial reactivity compared with Unc93b1 þ / þ mice (Figures 7f  and g ). The differential tissue pathology was coincident with a significantly higher viral load in the Unc93b1
Letr/Letr mice (Figure 7a ), suggesting that inflammation in the Unc93b1
Letr/Letr lungs may reflect a heightened response to increased viral replication. Analysis of lung tissue sections from uninfected mice did not show any difference between genotypes (Figures 7d and  e) . Taken together, these data indicate that impaired Unc93b1 function predisposes the host to a more severe initial disease course following influenza challenge; however, this difference does not significantly alter the ability of the Unc93b1
Letr/Letr mice to survive the infection.
DISCUSSION
The intricate balance between host immunity and pathogen virulence determines the outcome of an infection. ENU mutagenesis is an advantageous strategy for interrogation of the immune response to infection because it efficiently creates random heritable point mutations throughout the genome that may not occur through natural variation in inbred strains. 32 ENU can also cause distinct single-nucleotide alterations within a gene and create mutations that may closely resemble human conditions. 32 Using this technique, we screened for a recessive defect in TLR signaling in vitro to target immune processes that have an important role in microbial infection. 35 We discovered an alternative splicing mutation in Unc93b1, a gene that has been implicated in host immunity to diverse pathogens, and have identified a specific role for this gene in the innate immune response to influenza. Our findings demonstrate that Unc93b1 contributes to the early activation of ExMs and CD4 þ and CD8 þ / þ and Unc93b1 Letr/Letr lungs at day 0 (gray peaks) and day 3 (white peaks). Absolute number of (b) CD80
þ DCs and (c) CD80 þ ExMs in the lungs of Unc93b1 þ / þ (gray bars) and Unc93b1 Letr/Letr (white bars) mice at day 3 post infection. Data are representative of two independent experiments (n ¼ 6 per group). *Po0.05 determined by two-tailed unpaired t-test.
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Using a low-density genome scan, linkage analysis and nucleotide sequencing, we determined that the Letr mutation causes a T to A transversion at the 5 0 splice donor site in the intron between exons 4 and 5 of the Unc93b1 gene that results in the deletion of exon 4 in the spliced mRNA transcript. The Letr mRNA encodes a predicted protein that lacks the third and fourth transmembrane domains of the full-length UNC93B1. The 54-amino-acid residues eliminated by the Letr mutation are highly conserved between Mus musculus, Homo sapiens and other diverse organisms, suggesting that the two missing transmembrane helices encode important protein domains. Functional analysis using in vitro and in vivo PAMP stimulation clearly demonstrates that the ENU-induced Letr mutation is recessive and confers a complete loss of endosomal TLR function with no detectable pattern of codominance. Residual IL-6 production following polyI:C stimulation in mice or cells carrying the Letr mutation is most likely attributable to recognition by the cytosolic melanoma differentiation-associated protein 5 pathway. 57 Owing to the inherently random nature of ENU mutagenesis, one cannot control the genes, or sites within a gene, which are altered. A major advantage of this hypothesis-free approach is that screening for a particular phenotype can lead to the discovery of previously unknown genes as well as novel functions for known genes. 32 An earlier large-scale ENU mutagenesis study also identified a loss-of-function mutation, termed 3d, in the Unc93b1 gene and clearly established its role in immune responsiveness. 23 In contrast to the ENU-induced splicing mutation of Unc93b1 that we describe here, the 3d mutation causes a missense mutation in exon 9 that leads to a single-amino-acid substitution (H412R) in the ninth transmembrane domain of UNC93B1. Despite the different location and unique consequences of these two ENUinduced mutations, both produce a loss-of-function phenotype that confirms the essential contribution of the affected transmembrane-spanning domains to protein integrity. In vitro studies have shown that the 3d mutation inhibits UNC93B1 binding and trafficking of endosomal TLRs from the ER to the endosome following PAMP stimulation. 21, 22 A similar defect in stimulus-dependent trafficking to the plasma membrane was also observed with naturally occurring deletions of multiple transmembrane domains of the SLC7A7 transport protein. 58 Although we have not formally demonstrated that TLR binding and translocation is inhibited by the Letr mutation, in light of the predicted deletion of two transmembrane domains of the UNC93B1 protein, it is tempting to speculate that a related mechanism occurs as a result of this ENU-induced allele. Alternatively, deletion of two transmembrane domains of UNC93B1 could also cause a severe structural defect that abrogates protein production, as observed following the loss of a single transmembrane span from the 10-transmembrane domain glucose-6-phosphate protein. 59 Studies using Unc93b1 3d/3d mice have demonstrated an enhanced pathogen load and increased susceptibility to T. gondii, T. cruzi, L. major and MCMV infection in association with reduced expression of inflammatory mediators including IFN-g (T. cruzi, MCMV, L. major), IFN-a (MCMV) and IL-12p40 (T. gondii, T. cruzi). 23, 37, 38, 40, 42 The current report using Unc93b1 Letr/Letr mice extends the role of endosomal TLR-mediated inflammation to early host defense against influenza. Thus, the Unc93b1
Letr/Letr and Unc93b1 3d/3d mice represent alternative models for the study of diverse host-pathogen interactions. In contrast, Fukui et al. 60, 61 have shown that a point mutation in the cytoplasmic aminoterminus of UNC93B1 (D34A) causes lethal inflammation. 
intensity (MFI) of (c) CD69, (d) CD62L and (e) CD44 on Unc93b1
þ / þ and Unc93b1 Letr/Letr lung CD4 þ and CD8 þ T cells. Representative histograms for each activation marker show expression at day 0 (gray peak) and day 3 (white peak). Data are representative of two independent experiments for infected mice and one experiment for uninfected mice (n ¼ 4-6 per group). *Po0.05; ***Po0.001 determined by two-tailed unpaired t-test.
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Specifically, Unc93b1
D34A/D34A mice show preferential and constitutive transport of TLR7 over TLR9, resulting in a severe autoimmune phenotype in the absence of external stimulation. A comparison of the 3d, Letr and D34A mutations provides crucial insights into the structure-function relationship of UNC93B1 and demonstrates that unique point mutations of the Unc93b1 gene can confer a deficient or overexuberant immune phenotype.
Following influenza challenge, macrophages and DCs are among the first cells recruited to the respiratory tract. 62, 63 Pulmonary macrophages may be classified into two types: AMs that reside in naive lungs and elicit an early response along with respiratory epithelial cells, and monocyte-derived ExMs that are recruited from the bloodstream in a CCR2-dependent manner and differentiate into effector phagocytes that can lyse infected cells. 63, 64 Inflammatory DC subsets are also recruited from the bloodstream, take up antigen at the site of infection and traffic in a CCR7-dependent manner to the LALNs to activate naive T cells. 10 Both ExMs and inflammatory DCs express CD80; however, ExMs are relatively poor activators of naive T cells. 63, 65 At an early time point after influenza infection, we detected fewer activated CD80 þ ExMs, but not CD80 þ DCs, in the lungs of Unc93b1
Letr/Letr mice. This data reaffirm a role for Unc93b1 in antigen-presenting cell activation following infection 38 and is consistent with a previous study in which a lack of endosomal TLR signaling did not affect co-stimulatory molecule expression on DCs. 66 Residual antigen-presenting cell activation in our model can be attributed to alternative pathogen recognition mechanisms such as the nucleotide-binding domain and leucine-rich repeat containing receptor family, pyrin domain containing 3 (NLRP3) inflammasome in macrophages and DCs 67 or the cytosolic retinoic acid-inducible gene 1 (RIG-I) pathway in DCs. 68, 69 Recognition of viral infection in conventional DCs preferentially utilizes RIG-I signaling, 66, 68 while plasmacytoid DCs rely on TLR7. 16, 20 As plasmacytoid DCs are the main producers of type I IFN, it is plausible that the delayed expression of type I IFN in the airways of Unc93b1
Letr/Letr mice is due to defective TLR7-mediated activation of this specialized cell type. Conversely, the fact that conventional DCs produce type I IFN through a RIG-I-dependent mechanism 68, 70 may explain why the type I IFN response was diminished but not completely abolished in Unc93b1
Letr/Letr mice. Only the combined loss of MyD88 and mitochondrial antiviral signaling protein, the adaptor molecule for RIG-I and melanoma differentiation-associated protein 5, has been shown to completely abolish type I IFN signaling following influenza infection in vivo.
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At days 2 or 3 post infection with influenza, T cells in the LALNs downregulate CD62L and CCR7, proliferate, and subsequently traffic to the site of infection where they express various activation markers and acquire the capacity to secrete IFN-g. 56, 71 Consistent with an impaired activation state, CD4
þ and CD8 þ T cells in the lungs of Unc93b1
Letr/Letr mice showed a decrease in CD69 and a concomitant increase in CD62L expression at day 3 post infection. Importantly, TLRs have previously been shown to directly activate T cells. 72 Tlr1, Tlr2, Tlr3, Tlr6 and Tlr7 are expressed on both human peripheral blood and mouse C57BL/6 T cells [73] [74] [75] [76] and direct stimulation with TLR3 or TLR7 ligands promotes T-cell survival, CD38 and CD69 expression, and IFN-g production. 72, 73, 77, 78 Studies in murine lymphocytic choriomeningitis virus and T. gondii infection have demonstrated that the selective loss of MyD88 in T cells leads to decreased survival and IFN-g production 79, 80 and, in HIV-infected patients, direct TLR7 activation of CD8 þ T cells in vitro increased T-cell proliferation and IFN-g production. 81 As DC activation in Unc93b1
Letr/Letr mice appeared to be normal, the delayed lymphocyte activation phenotype in our model may represent an intrinsic defect in CD4 þ and CD8 þ T-cell activation caused by impaired Unc93b1 function. Nevertheless, at day 7 post infection, the CD4 þ and CD8 þ T-cell activation profile in Unc93b1 Letr/Letr lungs was comparable to the wild-type strain and most likely reflects increased infiltration of primed CD4 þ and CD8 þ T cells from the LALNs. 56, 71 Indeed, the formation of antigen-specific CD8 þ T cells and IFN-g þ CD4 þ T cells at later time points post infection can occur in the absence of TLR7 activation. 26, 82 Studies in MyD88-deficient mice have also demonstrated that signaling through this adaptor protein is not required for antigen-specific CD8 þ T-cell activation later in the infection, while evidence for the importance of MyD88 in CD4 þ T-cell activation is variable. 18, 26 Immune activation and cell migration following influenza infection is mediated by the expression of a large number of proinflammatory cytokines and chemokines. 10 In our model, the loss of Unc93b1 function led to a reduction in the expression of IFN-g, CXCL10 and type I IFN at day 3 post infection. Natural killer cells can produce IFN-g in response to IFN-a production by macrophages. 83 Accordingly, the diminished IFN-g response in the Unc93b1
Letr/Letr mice at this early time point may be attributable to fewer activated ExMs in the lung. At day 7 post infection, the comparable level of IFN-g between Unc93b1
Letr/Letr mice is most likely attributable to production by antigen-specific T cells. 56, 71 CXCL10 primarily attracts lymphocytes to the lungs and can be produced in response to Letr/Letr (white bars) mice at days 3 and 7 following influenza infection. Data are expressed as fold change compared with uninfected samples. Airway and lung expression of (b) CXCL10 and (c) IFN-g from Unc93b1 þ / þ and Unc93b1 Letr/Letr mice at days 3 and 7 post infection. Data are pooled from two independent experiments (nX9 per group). *Po0.05; **Po0.01; ***Po0.001 determined by two-tailed unpaired t-test.
IFN-g and by cells of both the innate and adaptive immune response, including ExMs. 84, 85 The reduced expression of CXCL10 in Unc93b1
Letr/Letr mice at day 3 post infection may also be linked to fewer activated ExMs with comparable induction at day 7 post infection mediated by infiltrating CD4 þ and CD8 þ T cells. 56, 71 The selective defect in proinflammatory mediator expression by Unc93b1
Letr/Letr mice following influenza infection is similar to observations in Unc93b1 3d/3d mice following T. gondii infection as 
38,41
In contrast to studies of Unc93b1 3d/3d mice that have shown increased mortality following infection with MCMV, neuroadapted Sindbis virus, T. cruzi and T. gondii, 23, 37, 38, 44 the Unc93b1
Letr/Letr mice and their wild-type counterparts had a comparable rate of survival following influenza infection. Nonetheless, during the innate immune response to influenza, Unc93b1 Letr/Letr mice exhibited several early immune defects including reduced myeloid cell recruitment, lymphoid cell activation and soluble inflammatory mediator production that collectively led to impaired viral clearance as well as increased tissue inflammation and epithelial reactivity during the course of infection. The different disease outcome in previous studies of Unc93b1 and the current report indicates that there is a limited requirement for Unc93b1 in the generation of protective immunity against influenza. Indeed, previous studies have shown that influenza activates a series of inflammatory pathways that could provide compensatory immunity in Unc93b1
Letr/Letr mice. For example, the cytosolic RIG-I signaling pathway, while not essential for survival, has been implicated in type I IFN expression from myeloid DCs, fibroblasts and human lung epithelial cells following influenza infection.
18,57,68 NLRP3-dependent activation of caspase-1 is also essential for survival of an influenza infection and the lack of either component leads to decreased recruitment of monocytes and neutrophils to the airways and lower expression of IL-1b, IL-18, CXCL1 and CXCL2 at day 3 post infection. 27, 52 Remarkably, in the absence of pattern recognition through TLR7 and mitochondrial antiviral signaling, IL-1R signaling in DCs was shown to be necessary and sufficient for the generation of virus-specific CD8 þ T-cell immunity against influenza. 82 Finally, our data highlight the differences in host response following systemic challenge with a purified PAMP that potently activates a single TLR and mucosal infection with a respiratory virus that activates multiple pattern recognition receptors with complementary and overlapping immune functions.
In summary, we have demonstrated that Unc93b1 Letr/Letr mice have defective endosomal TLR activation that diminishes innate immune responses at the site of infection during the early phase of influenza infection. Our study suggests two potential mechanisms by which Unc93b1 may contribute to innate immunity against influenza. First, Unc93b1-dependent type I IFN expression may stimulate ExMs that, in turn, enhance initial IFN-g production by natural killer cells and induces CXCL10. Second, Unc93b1 may mediate endosomal TLR signaling on CD4 þ and CD8 þ T cells that triggers their activation at the site of infection. Further detailed investigations of Unc93b1
Letr/Letr mice should reveal the exact mechanisms through which Unc93b1 regulates the innate immune response to influenza and, potentially, other viral respiratory pathogens.
MATERIALS AND METHODS
Ethics statement
All experiments using mice were performed according to the guidelines of the Canadian Council on Animal Care and approved by the Animal Use Care Committee of the McGill University Health Centre (Montré al, QC, Canada).
Mice, virus, cell lines C57BL/6 and 129S1 mice used for ENU mutagenesis and C3H/HeN mice used for breeding were purchased from Harlan Laboratories (Indianapolis, IN, USA). 
ENU mutagenesis and breeding
Mutagenesis of 8-to 12-week-old G0 male 129S1 mice was conducted as previously described using 150 mg kg À 1 of ENU. 86 Following fertility recovery (8-12 weeks after injection), mutagenized G0 males were crossed to C57BL/6 females in a three-generation breeding scheme for recessive ENU mutations. 87 G1 progeny from distinct G0 pairs were mated and G2 brother-sister matings were performed to produce 1200 G3 progeny for initial phenotypic screening. G2 fathers of G3 mice that displayed a deviant phenotype were outcrossed to C57BL/6 females and the resulting progeny were backcrossed to their G2 fathers. All backcross progeny were rephenotyped using survival splenectomy and deviant male and female animals were selected for creation of homozygous lines. Deviant animals were outcrossed to C3H/HeN mice and the F1 progeny were backcrossed to the deviant parent to generate 54 segregating mice used to map the genetic location of the mutation.
In vitro and in vivo phenotyping using PAMPs Whole spleens were removed, placed in 4 ml of RPMI (Gibco, Burlington, ON, Canada) supplemented with 1% L-glutamine (Gibco), 1% penicillin/ streptomycin (Gibco), 10% fetal bovine serum (Gibco) and 0.1% b-mercaptoethanol (Gibco) and mechanically disrupted using the frosted end of a microscope slide (Fisher Scientific, Toronto, ON, Canada). A singlecell suspension was created by multiple passages through an 18G 1'' and 21G 1 00 needle using a 5 ml syringe (BD Biosciences, Mississauga, ON, Canada). To obtain macrophages, mice were injected intraperitoneally with 1 ml of thioglycollate, prepared according to the manufacturer's instructions (BD Biosciences). Seventy-two hours later, cells were recovered by intraperitoneal lavage with 10 ml of incomplete RPMI. CpG oligodeoxynucleotide in 20 mg ml À 1 DGalN; 47 delivered in 1 ml of sterile PBS. Mice were killed 3 h after injection, blood was collected by cardiac puncture and serum was separated using the Z-Gel microtubes (Sarstedt). Cytokine and chemokine quantification was conducted using commercial ELISA kits (R&D Systems, Minneapolis, MN, USA).
Genotyping
Genomic DNA from a panel of 54 (Letr/Letr Â C3H/HeN) F1 Â Letr/Letr mice was submitted for typing of 375 informative single-nucleotide polymorphisms using a low-density Illumina genotyping platform and the Unc93b1 gene was sequenced using genomic DNA and cDNA derived from normal and deviant mice (The Centre for Applied Genomics, Toronto, ON, Canada). The primers used for genomic DNA sequencing were: EseqF 88 To determine the predicted three-dimensional protein structure, the wild-type UNC93B1 amino-acid sequence was entered into the Protein Homology/analogY Recognition Engine (Phyre), version 2.0 (Structural Bioinformatics Group, Imperial College, London, UK). 89 The predicted model, including the location of the 3d and Letr mutations, was visualized using the PyMol Molecular Graphics System, version 1.7 (Schrö dinger, LLC, Portland, OR, USA). 90 
In vivo influenza infection
Six-week-old Unc93b1 þ / þ and Unc93b1 Letr/Letr F2 mice were anesthetized by intraperitoneal injection of 150 mg kg À 1 of ketamine (Bioniche, PointeClaire, QC, Canada) and 10 mg kg À 1 of xylazine (Bayer, Toronto, ON, Canada) in sterile PBS and infected intranasally with 400 p.f.u. of influenza A/PR/8/34 (H1N1). Infected mice were monitored daily for signs of sickness and killed if they appeared moribund.
Flow cytometry
Lungs were extracted, placed in 5 ml of incomplete Dulbecco's modified Eagle's medium, finely chopped with a no. 23 scalpel and incubated with a further 5 ml of RPMI supplemented with 300 U ml À 1 of Collagenase (Sigma-Aldrich) for 1 h at 37 1C in 5% CO 2 . The tissue was then passed multiple times through a 16G 1'' needle and a 100 mM nylon strainer (BD Biosciences) and collected by centrifugation. LALN cells were prepared as described for splenocytes. Red blood cells were lysed with ACK buffer and cells were counted using a hemocytometer. Cells were stained with Fixable Viability Dye-efluor780 (eBioscience, San Diego, CA, USA) and, following a wash in sterile PBS, F c receptors were blocked using the anti-mouse CD16/CD32 (clone 93) antibody (eBioscience). Cells were then fluorescently labeled using cocktails of fluorescence-conjugated antibodies: rat anti-mouse CD45-V500 (clone 30-F11), rat anti-mouse Ly6G-Alexa Fluor 700 (clone 1A8), rat anti-mouse CD45R/B220-PECF594 (clone RA3-6B2) (BD Biosciences); anti-mouse/human CD11b-Brilliant Violet 711 (clone M1/ 70), anti-mouse CD11c-Brilliant Violet 605 (clone N418), anti-mouse CD80-PE (clone 16-10A1), anti-mouse CD8a-Alexa Fluor 700 (clone 53-6.7), antimouse CD62L-Brilliant Violet 605 (clone MEL-14), anti-mouse CD69-PE/Cy7 (clone H1.2F3) (BioLegend, San Diego, CA, USA); anti-mouse MHC class II (I-A/I-E)-PE/Cy7 (clone M5/114.15.2), anti-mouse CD3e-FITC (clone 145-2C11), anti-mouse CD4-eFluor450 (clone GK1.5), anti-mouse CD49b-allophycocyanin (clone DX5), anti-mouse CD44-PE (clone IM7) (eBioscience). Data were collected on the LSRFortessa using FacsDiva software version 6.2 (BD Biosciences) and analyzed using FlowJo, version 9.1 (Tree Star Inc., Ashland, OR, USA) with fluorescence-minus-one gating controls.
Bronchoalveolar lavage and lung inflammatory mediator quantification
After killing, bronchoalveolar lavage (BAL) fluid was collected from the airways by inserting a 22G 1 00 catheter into the mouse trachea and slowly injecting and removing four-0.5 ml aliquots of ice-cold sterile PBS. Cells were removed from BAL fluid by centrifugation. Lungs were perfused with 10 ml of sterile PBS via the right ventricle, excised and placed in 2 ml of sterile PBS supplemented with 1 Â Halt protease inhibitor cocktail (Fisher Scientific). Lungs were processed using a rotor-stator homogenizer (Fisher Scientific) and samples were centrifuged to pellet insoluble material. BAL fluid and lung homogenate were stored at À 80 1C until further analysis. ELISAs were used for protein quantification according to the manufacturer's instructions (R&D Systems). Type I IFN was quantified using B16-Blue cells that were cultured using standard techniques in RPMI media supplemented with 1% L-glutamine, 0.5% penicillin/streptomycin, 10% fetal bovine serum and 0.2% Normocin (InvivoGen). After two passages, cells were washed with sterile PBS and cultured in the same media with the addition of 0.1% Zeocin (InvivoGen) for an additional two or three passages. Twenty microliter per well of BAL sample, recombinant IFN-b (positive control) (PBL Interferon Source, Piscataway, NJ, USA) or sterile PBS (negative control) was added to a 96-well tissue culture plate and 7.56 Â 10 4 B16-Blue cells (in a volume of 180 ml) were added to these wells and incubated at 37 1C in 5% CO 2 for 24 h. Twenty microliter of this culture supernatant was added to a new 96-well plate containing 180 ml of QuantiBlue medium, prepared according to the manufacturer's instructions (InvivoGen), and incubated at 37 1C for 3.5 h. Absorbance was measured at 655 nm and type I IFN quantified as the fold change in expression relative to uninfected airway.
Viral quantification by plaque assay
Lungs were extracted from mice at multiple time points post infection and placed in incomplete Dulbecco's modified Eagle's medium (Wisent) at a 20% weight/volume ratio. Lungs were homogenized using a rotor-stator homogenizer and supernatants were collected by centrifugation. MadinDarby canine kidney cells were cultured using standard techniques in Dulbecco's modified Eagle's medium supplemented with 1% L-glutamine, 1% penicillin/streptomycin and 10% fetal bovine serum. Three to six cell passages were conducted before one million cells were plated per well on a six-well plate and incubated overnight at 37 1C in 5% CO 2 . Plaque assays were performed in a similar manner to a previous protocol. 91 Briefly, cells were washed twice with sterile PBS and 100 ml of serially diluted lung homogenate in incomplete Dulbecco's modified Eagle's medium was added. Following a 30-min incubation at 37 1C in 5% CO 2 , sample was removed and cells were covered with 3 ml of a 1:1 mixture of 1.6% agarose and 2 Â minimum essential medium (Gibco) supplemented with 6% of a 7.5% NaHCO 3 solution (BioShop Canada Inc., Burlington, ON, Canada), 1% L-glutamine, 2% penicillin/streptomycin and 0.1% TPCK-trypsin (SigmaAldrich). After a 48-h incubation at 37 1C in 5% CO 2 , 3 ml of a 3:1 methanol (Sigma-Aldrich) and acetic acid (Fisher Scientific) solution was added. After 4 h, the solution and agarose plugs were removed and plates were allowed to dry for 24 h. Plaques were visualized by staining with a 0.2% Crystal Violet solution in 20% ethanol (Sigma-Aldrich).
Lung histology
Lungs were flushed with 10 ml of PBS via the right ventricle. A catheter was inserted into the trachea and lungs were allowed to expand to a pressure of 25 cm using 10% buffered formalin acetate (Fisher Scientific). Inflated lungs were then placed in 5 ml of 10% buffered formalin acetate and subsequently embedded in paraffin, sectioned at 5 mm and stained with hematoxylin and eosin at the Histology Facility of the Goodman Cancer Research Centre (McGill University, Montré al, QC, Canada). Representative photographs of lung sections were taken using a BX51 microscope (Olympus, Richmond Hill, ON, Canada), QICAM Fast 1394 digital CCD camera (QImaging, Surrey, BC, Canada) and Image-Pro Plus software version 7.0.1.658 (Media Cybernetics, Rockville, MD, USA).
Statistical analysis
Survival curve analysis was performed using the log-rank test. For comparison between multiple columns a one-way analysis of variance with Dunnett's or Tukey's post-hoc test was used. A two-tailed unpaired t-test was conducted for all other pairwise comparisons. Statistical analysis was performed using GraphPad Prism 4 (GraphPad Software, La Jolla, CA, USA).
